Inactivation in Breast Cancer Molecular Mechanism of SLC5A8

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors

  2012cited by this paper
• Colon cancer cells maintain low levels of pyruvate to avoid cell death caused by inhibition of HDAC1/HDAC3.

  2009cited by this paper
• Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond.

  2009cited by this paper
• Sodium-Coupled Transport of the Short Chain Fatty Acid Butyrate by SLC5A8 and Its Relevance to Colon Cancer

  2008cited by this paper
• Sodium-coupled Monocarboxylate Transporters in Normal Tissues and in Cancer

  2008cited by this paper
• Lactaturia and Loss of Sodium-dependent Lactate Uptake in the Colon of SLC5A8-deficient Mice*

  2008cited by this paper
• Transport of Nicotinate and Structurally Related Compounds by Human SMCT1 (SLC5A8) and Its Relevance to Drug Transport in the Mammalian Intestinal Tract

  2007cited by this paper
• The epigenomics of cancer.

  2007cited by this paper
• Stem cells and cancer.

  2007cited by this paper
• CIMPle origin for promoter hypermethylation in colorectal cancer?

  2006cited by this paper
• SLC5A8 triggers tumor cell apoptosis through pyruvate-dependent inhibition of histone deacetylases.

  2006cited by this paper
• Cancer biology: A game of subversion

  2006cited by this paper
• Identity of SMCT1 (SLC5A8) as a neuron‐specific Na+‐coupled transporter for active uptake of l‐lactate and ketone bodies in the brain

  2006cited by this paper
• SLC5A8 (SMCT1)-mediated transport of butyrate forms the basis for the tumor suppressive function of the transporter.

  2006cited by this paper
• c/ebpδ Null Mouse as a Model for the Double Knock-out of slc5a8 and slc5a12 in Kidney*

  2006cited by this paper
• Oncogenic HRAS suppresses clusterin expression through promoter hypermethylation

  2006cited by this paper
• Silencing of the tumor suppressor gene SLC5A8 is associated with BRAF mutations in classical papillary thyroid carcinomas.

  2005cited by this paper
• Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway

  2005cited by this paper
• Sodium-coupled and electrogenic transport of B-complex vitamin nicotinic acid by slc5a8, a member of the Na/glucose co-transporter gene family.

  2005cited by this paper
• Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells

  2005cited by this paper
• Inhibitors of histone deacetylases target the Rb-E2F1 pathway for apoptosis induction through activation of proapoptotic protein Bim.

  2005cited by this paper
• Expression of slc5a8 in Kidney and Its Role in Na+-coupled Transport of Lactate*

  2004cited by this paper
• Colorectal cancer with mutation in BRAF, KRAS, and wild-type with respect to both oncogenes showing different patterns of DNA methylation.

  2004cited by this paper
• Functional Identification of SLC5A8, a Tumor Suppressor Down-regulated in Colon Cancer, as a Na+-coupled Transporter for Short-chain Fatty Acids*

  2004cited by this paper
• Histone deacetylase inhibitors upregulate death receptor 5/TRAIL-R2 and sensitize apoptosis induced by TRAIL/APO2-L in human malignant tumor cells

  2004cited by this paper
• Malignant MCF10CA1 Cell Lines Derived from Premalignant Human Breast Epithelial MCF10AT Cells

  2004cited by this paper
• The human tumour suppressor gene SLC5A8 expresses a Na+–monocarboxylate cotransporter

  2004cited by this paper
• SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers

  2003cited by this paper
• Silencing of H-ras gene expression by retrovirus-mediated siRNA decreases transformation efficiency and tumorgrowth in a model of human ovarian cancer

  2003cited by this paper
• Inhibition of histone deacetylase activity by butyrate.

  2003cited by this paper
• Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status

  2002cited by this paper
• The fundamental role of epigenetic events in cancer

  2002cited by this paper
• Mutations of the BRAF gene in human cancer

  2002cited by this paper
• Pancreatic cancer biology and genetics

  2002cited by this paper
• An old kinase on a new path: Raf and apoptosis

  2002cited by this paper
• The Raf/MEK/ERK pathway: new concepts of activation

  2001cited by this paper
• A Conserved 3′-Untranslated Element Mediates Growth Regulation of DNA Methyltransferase 1 and Inhibits Its Transforming Activity*

  2001cited by this paper
• Transcriptional regulation of the human DNA Methyltransferase (dnmt1) gene.

  2000cited by this paper
• Role of DNA 5-methylcytosine transferase in cell transformation by fos.

  1999cited by this paper
• DNA Methyltransferase Is a Downstream Effector of Cellular Transformation Triggered by Simian Virus 40 Large T Antigen*

  1999cited by this paper
• MCF10AT: a model for the evolution of cancer from proliferative breast disease.

  1996cited by this paper
• Increased cytosine DNA-methyltransferase activity is target-cell-specific and an early event in lung cancer.

  1996cited by this paper
• Suppression of intestinal neoplasia by DNA hypomethylation.

  1995cited by this paper
• Regulation of DNA methylation by the Ras signaling pathway

  1995cited by this paper
• Regulation of the DNA Methyltransferase by the Ras-AP-1 Signaling Pathway (*)

  1995cited by this paper
• Expression of an exogenous eukaryotic DNA methyltransferase gene induces transformation of NIH 3T3 cells.

  1993cited by this paper
• Targeted mutation of the DNA methyltransferase gene results in embryonic lethality.

  1992cited by this paper
• High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer.

  1991cited by this paper
• DNA methylation patterns: an additional level of information?

  1991cited by this paper
• ras oncogenes in human cancer: a review.

  1989cited by this paper
• Evidence of enhancement of the ras oncogene protein product (p21) in a spectrum of human tumors

  1989cited by this paper
• Quantitation of Harvey ras p21 enhanced expression in human breast and colon carcinomas.

  1987cited by this paper
• DNA methyltransferase levels in tumorigenic and nontumorigenic cells in culture.

  1986cited by this paper
• Specific activation of the cellular Harvey-ras oncogene in dimethylbenzanthracene-induced mouse mammary tumors

  1986cited by this paper
• Expression of the 21,000 molecular weight ras protein in a spectrum of benign and malignant human mammary tissues.

  1986cited by this paper
• Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats

  1985cited by this paper
• Human malignant tumours of the breast, as compared to their respective normal tissue, have elevated expression of the Harvey ras oncogene.

  1984cited by this paper
• Chromatin Modifications and Their Function

  year unknowncited by this paper

• No citing papers are available for this paper.